Amarin Corp Plc (AMRN)

[Whalatane]

Roughly 3 months ago Kaiser used to charge me around $100 a month for both Vascepa and Repatha

Now Kaiser charges me $12 a month for Vascepa and $143 a month for Repatha

This is Medicare … no coupon card … and it’s Brand Vascepa
To my knowledge Kaiser does not dispense Generic Vascepa

So why do you think Kaiser has dropped my co pay so much ?
Got a great WAC deal from Amarin ?
Have internal real world data showing reduction in events in my profile type patients ?
Or they just felt generous … charging way less then what it costs them .

I’ll go with a combination of the first 2 options

There are 3 catalysts I see for this stock .
P-It 2 data maybe at AHA in Nov
MITIGATE data in late March / April 2022
Settlement of the Infringement case .

This story is not over ( next 1-2 yrs ) unless all 3 of the potential catalyst’s above are a bust .

The EU launch imho near term is a cash burn non event

Kiwi